MeSH Review:
Encephalomyelitis, Venezuelan Equine
Bonilla,
Valero,
Chacín-Bonilla,
Pons,
Larreal,
Medina-Leendertz,
Espina,
Nikiforova,
Velikodvorskaja,
Kachko,
Nikolaev,
Monastyrskaya,
Lukyanov,
Konovalova,
Protopopova,
Svyatchenko,
Kiselev,
Loktev,
Sverdlov,
Lukaszewski,
Brooks,
Thomas,
Zhu,
Van Dam,
Davis,
Johnston,
Sparling,
Phillpotts,
O'brien,
Appleton,
Carr,
Bennett,
- Induction of alternatively spliced spermidine/spermine N1-acetyltransferase mRNA in the human kidney cells infected by venezuelan equine encephalitis and tick-borne encephalitis viruses. Nikiforova, N.N., Velikodvorskaja, T.V., Kachko, A.V., Nikolaev, L.G., Monastyrskaya, G.S., Lukyanov, S.A., Konovalova, S.N., Protopopova, E.V., Svyatchenko, V.A., Kiselev, N.N., Loktev, V.B., Sverdlov, E.D. Virology (2002)
- Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus. Phillpotts, R.J., O'brien, L., Appleton, R.E., Carr, S., Bennett, A. Vaccine (2005)
- Genetic variation of Venezuelan equine encephalitis virus strains of the ID variety in Colombia. Rico-Hesse, R., Roehrig, J.T., Trent, D.W., Dickerman, R.W. Am. J. Trop. Med. Hyg. (1988)
- Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus. Bennett, A.M., Phillpotts, R.J., Perkins, S.D., Jacobs, S.C., Williamson, E.D. Vaccine (1999)
- Generation of recombinant norovirus-like particles (VLP) in the human endothelial kidney cell line 293T. Taube, S., Kurth, A., Schreier, E. Arch. Virol. (2005)
- Vector infection determinants of Venezuelan equine encephalitis virus reside within the E2 envelope glycoprotein. Brault, A.C., Powers, A.M., Weaver, S.C. J. Virol. (2002)
- Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection. Lukaszewski, R.A., Brooks, T.J. J. Virol. (2000)
- Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins. Spotts, D.R., Reich, R.M., Kalkhan, M.A., Kinney, R.M., Roehrig, J.T. J. Virol. (1998)
- Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. Caley, I.J., Betts, M.R., Irlbeck, D.M., Davis, N.L., Swanstrom, R., Frelinger, J.A., Johnston, R.E. J. Virol. (1997)
- Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles. Thomas, C.E., Zhu, W., Van Dam, C.N., Davis, N.L., Johnston, R.E., Sparling, P.F. Infect. Immun. (2006)
- Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. Mathews, J.H., Roehrig, J.T., Trent, D.W. J. Virol. (1985)
- Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus. Bonilla, E., Valero-Fuenmayor, N., Pons, H., Chacín-Bonilla, L. Cell. Mol. Life Sci. (1997)
- Evaluation of various analogues of tilorone hydrochloride against Venezuelan equine encephalitis virus in mice. Kuehne, R.W., Pannier, W.L., Stephen, E.L. Antimicrob. Agents Chemother. (1977)
- Protective and toxic effects of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid on Venezuelan equine encephalomyelitis virus in rhesus monkeys. Stephen, E.L., Hilmas, D.E., Levy, H.B., Spertzel, R.O. J. Infect. Dis. (1979)
- Free amino acids in the striatum of mice infected with Venezuelan equine encephalomyelitis virus. Bonilla, E., Prasad, A.L., Estévez, J., Hernández, H., Arrieta, A. Exp. Neurol. (1986)
- Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate. Charles, P.C., Brown, K.W., Davis, N.L., Hart, M.K., Johnston, R.E. Virology (1997)
- Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Johnson, B.J., Brubaker, J.R., Roehrig, J.T., Trent, D.W. Virology (1990)
- Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attenuation of Venezuelan equine encephalitis virus. Johnson, B.J., Kinney, R.M., Kost, C.L., Trent, D.W. J. Gen. Virol. (1986)
- Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes. Cassetti, M.C., McElhiney, S.P., Shahabi, V., Pullen, J.K., Le Poole, I.C., Eiben, G.L., Smith, L.R., Kast, W.M. Vaccine (2004)
- Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice. Schoneboom, B.A., Lee, J.S., Grieder, F.B. J. Interferon Cytokine Res. (2000)
- Effect of Venezuelan equine encephalomyelitis virus infection on brain choline acetyltransferase and acetylcholinesterase activities. Bonilla, E., Hernández, H., Salazar, M., Rangel, P. Brain Res. (1982)
- Melatonin increases interleukin-1beta and decreases tumor necrosis factor alpha in the brain of mice infected with the Venezuelan equine encephalomyelitis virus. Bonilla, E., Valero, N., Chacín-Bonilla, L., Pons, H., Larreal, Y., Medina-Leendertz, S., Espina, L.M. Neurochem. Res. (2003)
- Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. Burke, D.S., Ramsburg, H.H., Edelman, R. J. Infect. Dis. (1977)
- Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Davis, N.L., Powell, N., Greenwald, G.F., Willis, L.V., Johnson, B.J., Smith, J.F., Johnston, R.E. Virology (1991)